Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Multidomain Approach Through Biopsychosocial Pathways (MAP) Intervention for Older Adults With Age-Related Hearing Loss

11 november 2026 bijgewerkt door: The Hong Kong Polytechnic University

Development and Preliminary Evaluation of a Multidomain Approach Through Biopsychosocial Pathways (MAP) Intervention for Older Adults With Age-Related Hearing Loss: Pilot Randomized Controlled Trial

Background With population aging accelerating worldwide, age-related hearing loss (ARHL) has become one of the most prevalent sensory impairments among older adults, with global prevalence rising from 12.7% at age 60 to over 58% by age 90. The communication difficulties, reduction in daily-life activities, and social stigma associated with hearing loss can contribute to increased loneliness in older adults. This condition affects approximately 25% of older adults in mainland China and 46% in Hong Kong and is associated with depression, increased mortality risk, and elevated healthcare utilization. Addressing loneliness in this population is therefore essential not only for older adults' own health and wellbeing, but also for promoting healthy aging and sustainable community-based care. However, limited studies have examined the associations between loneliness and physical, psychosocial, and hearing health status among older adults with ARHL in real-life living environments and no qualitative study has explored their perceptions and experiences of loneliness. The built environment may influence both hearing health and loneliness among older adults by shaping communication opportunities, social participation, mobility, and access to supportive resources. Therefore, examining the relationships among loneliness, hearing difficulties, and the built environment is important for understanding how everyday living contexts contribute to or mitigate loneliness in later life. Furthermore, existing intervention studies have concentrated mainly on hearing aids and cochlear implants. However, loneliness in this population arises not only from reduced auditory input, but also from psychological distress, social exclusion, and limited opportunities for social engagement, all of which are factors that hearing correction alone cannot directly resolve. These gaps limit the evidence base needed to understand and address loneliness in this population and hinder the development of multi-component interventions for older adults with ARHL.

Aim This study aims 1) to explore the perceptions and experiences of loneliness and social engagement among older adults with ARHL; 2) to examine the associations between loneliness and physical, psychosocial, hearing health, and built environment factors; and 3) to develop and preliminarily evaluate a Multidomain Approach through Biopsychosocial Pathways (MAP) intervention to address loneliness in this population.

Methods A sequential exploratory mixed methods design was adopted, underpinned by the Socio-Ecological Model. This study will be conducted in three phases. First, a qualitative descriptive methodology was used among community-dwelling older adults with ARHL to explore their perceptions and experiences of loneliness and social engagement. Second, a cross-sectional study, with GIS-based spatial analysis will be conducted to examine the associations between loneliness and physical, psychosocial, hearing health, and built-environment factors. Last, a pilot randomized controlled trial will be conducted to evaluate the feasibility, acceptability, and preliminary effects of MAP, underpinned by the biopsychosocial model and findings of previous phases to reduce loneliness among older adults with ARHL.

Expected outcomes This study is expected to 1) provide in-depth qualitative evidence on the perceptions and experiences of loneliness and social engagement among older adults with ARHL; 2) identify multilevel correlates of loneliness, spanning physical, psychosocial, hearing health, and built environment factors; 3) evaluate the feasibility, acceptability, and preliminary effects of MAP on loneliness, thereby informing the design of a future definitive trial and community-based service planning for this population.

Studie Overzicht

Studietype

Ingrijpend

Inschrijving (Geschat)

60

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

60 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  1. aged 60 years or older and living in the community;
  2. mild-to-moderate hearing loss, defined as a pure-tone average (PTA) of 20-50 dB across octave frequencies from 0.5 to 4 kHz in both ears;
  3. experiencing loneliness (De Jong Loneliness Scale score ≥ 3);
  4. willingness and ability to provide informed consent and comply with study procedures.

Exclusion Criteria:

  1. a history of psychosis, mania, bipolar disorder, substance use disorder, or suicidal ideation;
  2. severe or unstable medical illness;
  3. significant retro cochlear pathology or an organic lesion causing hearing loss;
  4. a diagnosis of probable Alzheimer disease, vascular dementia, frontotemporal dementia, or Parkinson disease;
  5. regular engagement in mindfulness or other mind-body practices (>2 times weekly).

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Dubbele

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Multidomain Approach through Biopsychosocial Pathways (MAP) intervention

The intervention group will receive a Multidomain Approach through Biopsychosocial Pathways (MAP) intervention comprising self-administered auricular acupressure, video-guided mindfulness practice adapted from Mindfulness-Based Stress Reduction (MBSR), and a GIS-guided community engagement programme, delivered concurrently over an 8-week period.

The intervention group will receive a Multidomain Approach through Biopsychosocial Pathways (MAP) intervention comprising self-administered auricular acupressure, video-guided mindfulness practice adapted from Mindfulness-Based Stress Reduction (MBSR), and a GIS-guided community engagement programme, delivered concurrently over an 8-week period.

Placebo-vergelijker: Control group

The control group will receive reading materials on ARHL, loneliness, and hearing health education. The control group will receive delayed access to the Multidomain Approach through Biopsychosocial Pathways (MAP) intervention after completion of the final follow-up assessment.

The control group will receive reading materials on ARHL, loneliness, and hearing health education. The control group will receive delayed access to the Multidomain Approach through Biopsychosocial Pathways (MAP) intervention after completion of the final follow-up assessment.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Adherence to the three intervention components
Tijdsspanne: Throughout the 8-week intervention period

Intervention adherence rates for the three components (Auricular acupressure self-administration, completion rate of weekly video-guided mindfulness sessions, and engagement with the GIS-guided community engagement programme) will be assessed using self-reported logs completed independently by older participants via paper booklets. For each component, adherence will be calculated as the number of completed sessions divided by the total number of prescribed sessions during the 8-week intervention period, multiplied by 100. Scores range from 0% to 100%, with higher percentages indicating greater adherence to the respective intervention schedule.

Throughout the 8-week intervention period
Usage Frequency to the three intervention components
Tijdsspanne: Throughout the 8-week intervention period

The adherence to the three intervention components was assessed using self-reported logs completed independently by older participants via paper booklets. A usage session was defined as one recorded episode of engaging in each respective activity. Adherence for each component was quantified as the mean number of sessions completed per week across the 8-week intervention period, with higher values indicating more frequent engagement.

Throughout the 8-week intervention period
Participant retention rate
Tijdsspanne: Week 8

The participant retention rate will be calculated as the number of enrolled participants who remain in the study and have not withdrawn by Week 8 divided by the total number of participants enrolled, multiplied by 100. Scores range from 0% to 100%, with higher percentages indicating greater participant retention.

Week 8
The follow-up assessment completion rate
Tijdsspanne: Week 8

The follow-up assessment completion rate will be calculated as the number of participants who complete the scheduled Week 8 follow-up assessment divided by the total number of enrolled participants expected to complete the assessment, multiplied by 100. Scores range from 0% to 100%, with higher percentages indicating greater follow-up completion.

Week 8
Acceptability of the intervention assessed by semi-structured interviews
Tijdsspanne: Week 8, following completion of the intervention

All participants in the intervention group will be invited to take part in an individual interview after completing the intervention, to explore their experiences of participating in the Multidomain Approach through Biopsychosocial Pathways (MAP) intervention and their perceptions of its acceptability. Interview data will be analyzed using thematic analysis and reported as themes and subthemes related to participants' experiences and perceived acceptability. No numerical scale score will be calculated.

Week 8, following completion of the intervention

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Loneliness
Tijdsspanne: Baseline and Week 8

Loneliness will additionally be assessed as a preliminary indicator of intervention effect. This is the outcome proposed as the primary outcome for a future definitive trial. Change in loneliness from baseline to post-intervention will be measured using the Mandarin version of the 6-item De Jong Gierveld Loneliness Scale (DJGLS).

Baseline and Week 8
Sleep quality
Tijdsspanne: Baseline and Week 8

Sleep quality will be assessed using the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI), administered at baseline and post-intervention.

Baseline and Week 8
Subjective hearing difficulty
Tijdsspanne: Baseline and Week 8

Subjective hearing difficulty will be measured using the 18-item Revised Hearing Handicap Inventory (R-HHI), administered at baseline and post-intervention.

Baseline and Week 8
Depressive symptoms
Tijdsspanne: Baseline and Week 8

Depressive symptoms will be screened with the Patient Health Questionnaire-2 (PHQ-2), administered at baseline and post-intervention.

Baseline and Week 8
Community resource utilization
Tijdsspanne: Baseline and Week 8

As no validated instrument exists for this intervention-specific component, a study-designed weekly tick-box log will be used to record visits to GIS-recommended resources (hearing service centers or community/green space facilities), with participants choosing a paper or electronic format based on preference. Logs will be submitted at the post-intervention assessment, with paper records transcribed into the same database as electronic entries. The primary metric will be the cumulative number of resource visits over the intervention period.

Baseline and Week 8

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 december 2026

Primaire voltooiing (Geschat)

1 januari 2028

Studie voltooiing (Geschat)

30 juni 2028

Studieregistratiedata

Eerst ingediend

11 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

11 november 2026

Eerst geplaatst (Werkelijk)

17 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

17 november 2026

Laatste update ingediend die voldeed aan QC-criteria

11 november 2026

Laatst geverifieerd

1 augustus 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren